← Back to Search

Exercise for Prostate Cancer

Phase < 1
Waitlist Available
Led By Celina Shirazipour, PhD
Research Sponsored by Celina Shirazipour
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

Study Summary

This trial will study whether web-based video conferencing can effectively deliver exercise training to breast and prostate cancer survivors.

Eligible Conditions
  • Prostate Cancer
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence
Attendance
Manipulation check
+1 more
Secondary outcome measures
Changes in body composition (baseline - end of study visit)
Changes in body composition (baseline - mid-study visit)
Changes in body composition (mid-study visit - end of study visit)
+10 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: ExerciseExperimental Treatment1 Intervention
For the first 12 weeks on study (Part 1), participants will train with an exercise physiologist (EP) for 150 minutes/week. This training will be delivered by web-based video conferencing. For the next 12 weeks (Part 2), participants will be instructed to do patient-directed exercise.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise
2016
Completed Phase 1
~760

Find a Location

Who is running the clinical trial?

Celina ShirazipourLead Sponsor
Celina Shirazipour, PhDPrincipal Investigator - Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
1 Previous Clinical Trials
20 Total Patients Enrolled
1 Trials studying Prostate Cancer
20 Patients Enrolled for Prostate Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research still recruiting participants?

"As of now, clinicaltrials.gov reports that this experimental trial is actively recruiting patients; the initial listing was posted on July 7th 2020 and last updated October 13th 2022."

Answered by AI

What is the sample size of this clinical experiment?

"Yes, current information on clinicaltrials.gov states that this trial is seeking participants. The advertisement was first posted on July 7th 2020 and updated October 13th 2022. 20 people are required to join the study at a single site."

Answered by AI

What are the main aims of this research project?

"The primary metric of this 12-week experiment is Adherence, with secondary endpoints including Changes in body composition (mid-study visit - end of study visit) as measured by Bio-Electrical Impedance Analysis through InBody, Changes in body composition (baseline - end of study visit), and Alterations to resting heart rate from baseline to the conclusion."

Answered by AI
~3 spots leftby Apr 2025